Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes

详细信息    查看全文

• 作者：Ryotaro Asano^a ; ^{asano201@gmail.com} ; Katsuya Kajimoto^b ; Toshiaki Oka^a ; Ryo Sugiura^a ; Hisayuki Okada^a ; Kazuho Kamishima^a ; Tetsuo Hirata^a ; Naoki Sato^c ; on behalf of the investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry
• 关键词：Acute heart failure syndromes ; New York Heart Association functional class ; In-hospital outcome ; Assessment
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：1 March 2017
• 年：2017
• 卷：230
• 期：Complete
• 页码：585-591
• 全文大小：646 K
• 卷排序：230

文摘

It remains unclear whether there are subgroups of acute heart failure syndromes (AHFS) patients in whom New York Heart Association (NYHA) class IV symptoms at admission is related to a higher risk of mortality because of the heterogeneity of this patient population. The aim of this study was to evaluate the association of NYHA class IV symptoms at baseline with in-hospital mortality in subgroups of patients with AHFS.Methods and ResultsOf the 4842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry, 4786 patients were included in this analysis. The primary endpoint was in-hospital all-cause death. NYHA class IV at baseline was detected in 44.3% of the patients. The all-cause death rate was significantly higher in patients with NYHA class IV than in those with NYHA class II or III (9.0% vs. 4.3%, P < 0.001). To examine the heterogeneity of the association between NYHA class IV symptoms at baseline and in-hospital mortality, subgroup analyses were performed. As a result, the presence of NYHA class IV symptoms on admission was associated with a significantly higher risk of all-cause death in patients aged ≥ 75 years, female patients, patients without an idiopathic dilated etiology, and patients with preserved ejection fraction (EF).ConclusionsThis study demonstrated that an age ≥ 75 years, female gender, the absence of idiopathic dilated etiology, and a preserved EF should be considered when assessing the clinical significance of NYHA class IV symptoms in relation to the risk of in-hospital mortality in patients hospitalized for AHFS.